drugset / Trial / NCT02504008
CREATE-1: A Study to Assess the Efficacy and Safety of AXS-02 in Patients With CRPS-1
RandomizedParallel-groupDouble-blindTreatment
Summary
This is a randomized, double-blind, placebo-controlled, 24-week study to evaluate the efficacy and safety of AXS-02 in patients with CRPS-I.
Timeline
- Start
- 2015-07
- Primary completion
- 2019-01
- Completion
- 2019-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Zoledronate | Other / unclassified | — | Oral |